Status:
COMPLETED
Third Generation Cognitive Behavioural Therapy vs Treatment-as-usual for ADHD
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Adhd
Eligibility:
All Genders
7-15 years
Brief Summary
The investigators hypothesize that the mindfulness Cognitive Behavioral Therapy program will lead to a reduction in attention deficit and hyperactivity disorder symptoms, anxiety and depression, and i...
Eligibility Criteria
Inclusion
- If deemed able, the patient must have given his/her informed and signed consent
- The parents (or legal guardian) of minor patients must have given their informed and signed consent.
- The patient and participating parents must be insured or beneficiary of a health insurance plan
- The patient is equal to or greater than 7 years old and less than or equal to 15 years old
- The patient presents with attention deficit and hyperactivity disorder with an ADHDRS-PI score \> 27
- The patient is currently not under treatment - OR - is treated with methylphenidate with a stable posology (not expected to vary in the near future) but remains symptomatic
Exclusion
- The patient is participating in, or has participated in over the past three months, another trial or another study that may interfere with the results or conclusion of the present study
- The patient is in an exclusion period determined by a previous study
- The participating parent(s) is(are) under judicial protection, or is an adult under guardianship
- It is impossible to correctly inform the patient or his/her parent or legal guardian
- Patients or parents refusing participation, signature of the signed consent or follow-up procedures
- Previously documented mental retardation (IQ \< 70) or suspicion thereof by the investigator
- The patient has already participated in cognitive behavioural therapy (individual or group) in the six months preceding inclusion
- Patients diagnosed with autism spectrum disorder, psychotic disorder or bipolar disorder
- The family has participated in a parental guidance programme in the last 6 months.
- The family has already participated in the present study
Key Trial Info
Start Date :
February 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 23 2022
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT03437772
Start Date
February 19 2018
End Date
November 23 2022
Last Update
January 4 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Montpellier
Montpellier, France, 34295
2
CHU Nimes
Nîmes, France, 30029
3
APHP - Hôpital Robert Debré
Paris, France, 75935
4
Chu de Strasbourg
Strasbourg, France, 67091